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Background: In-stent neoatherosclerosis is characterized by the delayed appearance of markers of atheroma in
the subintima, but the pathophysiology underlying this new disease entity remains unclear.
Methods and results:We collected 20 human coronary artery stents by removal from explanted hearts. Themean
duration of stent implantation was 34 months. In all samples, neoatherosclerosis was detected, particularly in
peristrut areas. It consisted of foam cells and cholesterol clefts, with or without calciﬁcation, associatedwith neo-
vascularization. Iron and glycophorin-Awere present in peristrut areas, aswell as autoﬂuorescent ceroids.More-
over, in response to neoatherosclerosis, tertiary lymphoid organs (tissue lymphoid clusters) often developed in
the adventitia. Some of these features could be reproduced in an experimental carotid stenting model in rabbits
fed a high-cholesterol diet. Foam cells were present in all samples, and peristrut red blood cells (RBCs) were also
detected, as shown by iron deposits and Bandeiraea simpliciﬁola isolectin-B4 staining of RBCmembranes. Finally,
in silico models were used to evaluate the compliance mismatch between the rigid struts and the distensible ar-
terial wall using ﬁnite element analysis. They show that stenting approximately doubles the local von Mises
stress in the intimal layer.
Conclusions:We show here that stent implantation both in human and in rabbit arteries is characterized by local
peristrut microhemorrhages and ﬁnally by both cholesterol accumulation and oxidation, triggering together in-
stent neoatherosclerosis. Our data indicate that these processes are likely initiated by an increased mechanical
stress due to the compliance mismatch between the rigid stent and the soft wall.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Atherosclerotic lesions are major causes of death throughout the
world [1]. The most vulnerable or unstable lesions are characterized
by the presence of intraplaque hemorrhages [2]. Red blood cell (RBC)
membranes represent an important source of nonesteriﬁed cholesterol
and hemoglobin, a source of reactive iron,which catalyzes oxidation [2].
Coronary stents have been developed in order to increase the luminal
diameter at the site of stenosis with the aim of relieving myocardialopean Union under the Seventh
tent Thrombosis by an Interdis-
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. This is an open access article underischemia [3]. After stent implantation, intimal vascular smooth muscle
cell (vSMC) hyperplasia takes place [4], leading to recurrent luminal
narrowing (i.e., in-stent restenosis) [5]. To attempt to prevent this vSMC
proliferation, bare-metal stents (BMSs) have been superseded by drug-
eluting stents (DESs), coated with various antiproliferative drugs. Al-
though the use of DESs has reduced the risk of in-stent restenosis, stent
obstruction due to the development of in-stent neoatheroma and/or
acute stent thrombosis [6] still remains an important clinical issue.
In-stent neoatherosclerosis may participate in complications after
stent implantation, both by causing stenosis and by triggering thrombo-
sis [7]. It corresponds to the delayed appearance, within the arterial tis-
sue in close proximity to the stent struts, of lesions which share
histopathologic characteristics with primitive atherosclerosis [8]. They
appear more frequently (64% vs. 31%) and earlier (2 years after implan-
tation, 29% vs. 0%) within DESs as compared to BMSs [7]. Karanasos
et al., in a clinical study using optical coherence tomography (OCT),the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Deﬁnitions
Deﬁnitions Reference
to ﬁgure
Foam cells Fat-laden phagocytes (macrophages and/or
smooth muscle cells) seen in atherosclerosis
1, 4, 5
Cholesterol
cleft/crystal
Empty cleft present in deparaﬁnized section
corresponding to accumulation of cholesterol
crystal (giving the geometrical aspect of the clefts)
1
Calciﬁcation Localized accumulation of hydroxyapatite crystals 1
Neovessel Acquired angiogenesis from adventitia toward
media
5
Ceroids Autoﬂuorescent (550–605 nm) insoluble
aggregates of lipids and proteins due to oxidation
3, 5
Tertiary
lymphoid
organs
Tissue lymphoid clusters in which adaptive
immune maturation takes place, absent from
media and usually present in the adventitia
2
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thrombosis [9]. To date, the pathophysiology underlying this new dis-
ease entity remains unclear. However, it is well established that intra-
mural RBCs stimulate atherosclerosis via an accumulation of
cholesterol-richmembranes and the promotion of local oxidative activ-
ities catalyzed by hemoglobin/iron release [2,10].
In order to explore the mechanism of intrastent neoatherosclerosis,
we performed a detailed observation of human coronary stents obtain-
ed fromexplanted hearts in patients having undergone heart transplan-
tation and used a stenting model in hypercholesterolemic rabbits to
demonstrate the point. In addition, we used an in silico biomechanical
approach to evaluate the compliancemismatch between the rigid struts
and the distensible arterial wall during the cardiac cycle as the possible
cause of peristrut microhemorrhages.
2. Methods
2.1. Human explanted hearts
Since 2010, 34 patients have received a heart transplant for ischemic
heart disease in Xavier Bichat hospital in Paris. Among these patients, 10
had at least 1 coronary stent implanted before the transplantation and
were included in the present analysis. The Institutional Review Board,
IRB 0006477 of Hôpitaux Universitaires Paris-Nord Val de Seine, Paris
7 University, and Assistance Publique-Hôpitaux de Paris approved the
use of explanted hearts for research. Following heart explantation,
stented segments were removed, ﬁxed in 4% PFA for 48 h, and then em-
bedded in a methyl methacrylate resin. We collected 13 BMSs and 7
DESs (2 paclitaxel-, 2 zotarolimus-, and 2 everolimus-eluting stents
and 1 unknown). Clinical data from transplanted patients are presented
in Supplementary data and Supplementary Table 1.
2.2. Rabbit model of carotid atherosclerosis
Thirteen New Zealand white rabbits (mean weight, 3.5 kg; mean
age, 4 months) were fed a 0.3% cholesterol-enriched diet as described
[11]. After 15 days of high-fat diet, stents (6 BMSs and 7 DESs) were im-
planted in the right carotid artery using a right femoral access allowing
the positioning of a 5-French introducer (Terumo, Tokyo, Japan) under
general anesthesia. Stent characteristics are presented in Supplemental
data. A 0.014-in. hydrophilic guidewire (Croos-it; Guidant, Indianapolis,
IN, USA) permitted stent implantation (12 atm during 30 s). An intrave-
nous bolus of 1000 IU of heparin sodium (Heparin Choay; Sanoﬁ, Paris,
France) was given immediately prior to stent implantation. Rabbits
were sacriﬁced 4 weeks later by injection of a lethal dose (35 mg/kg)
of sodium pentobarbital (Ceva Santé Animale, Paris, France), and the
13 stents were removed. The noninjured left carotid arteries were also
collected and served as controls. This rabbit experimental design re-
ceived approval from the Institutional Committee on Animal Research
and Ethics (CARE, North Paris, no. 121, Paris 7 University) and was de-
clared to the French Ministry of Research, no. 2012-15/698-0080.
2.3. Histological preparation
All arterial samples were embedded inmethyl methacrylate (except
controls, in parafﬁn) and cut into 12-μm-thick cross-sections using a
dedicated microtome. Sections of stented arteries were depolymerized
in a 2-methoxyethyl acetate solution and then stained.
Masson's trichrome stainingwas used for general histology and Aliz-
arin red staining for calciﬁcation analysis. Perl's reactionwas performed
on all the samples, alone or ampliﬁed by 3,3′-diaminobenzidine (DAB)
precipitation, to assess the presence of iron [12]. Alcian blue staining
was used to identify glycosaminoglycans, with nuclear red
counterstaining. vSMCs were detected with an anti-α-smooth muscle
actin antibody in human (Abcam, Cambridge, UK) and in rabbit (Dako,
Carpinteria, CA, USA) samples, revealed by DAB, with hematoxylincounterstaining. Phagocytes were identiﬁed with an anti-CD68 anti-
body in human samples (Dako, Carpinteria, CA, US) and the use of a
DL649-conjugated secondary antibody (JIR 111496046; Johnson
ImmunoResearch, West Grove, US). The RAM11 antibody was used to
detect phagocytes in rabbit samples (Dako, Carpinteria, PA, USA), re-
vealed by DAB, and counterstained with hematoxylin.
For the localization of RBC membranes in human samples, we used
an anti-glycophorin A antibody (Abcam, Cambridge, UK), revealed by
TRITC-conjugated secondary antibody (JIR 115026071; Johnson
ImmunoResearch, West Grove, PA, USA). In rabbit samples, we used
Bandeiraea simplicifolia isolectin-B4 (Sigma Chemicals, Perth,
Australia), as previously described [13], with hematoxylin
counterstaining. In order to detect ceroids, autoﬂuorescence was ob-
served at an emissionwavelength of 605 nm [14] (see Table 1 for histo-
logical terms deﬁnitions).
To characterize the tertiary lymphoid organs (tissue lymphoid clus-
ters), we performed immunostaining with anti-CD3 (pan-T antibody;
Dako, Carpinteria, CA, USA) and anti-CD20 (B cell; Dako, Carpinteria,
CA, USA) antibodies, which were respectively revealed by TRITC-
conjugated (JIR 115026071; Johnson ImmunoResearch, West Grove, PA,
USA) and DL649-conjugated (JIR 111496046; Johnson ImmunoResearch,
WestGrove, PA, USA) secondary antibodies. This classical histologywas com-
pleted by a whole mount clearing technique, detailed in Supplemental data.
2.4. Biomechanics
In order to investigate stress concentration caused by coronary
stenting, a ﬁnite element (FE) model was used [15] and detailed in Sup-
plemental data.
2.5. Statistical analysis
Quantitative variables are expressed asmeans ± standard deviation
and were compared using a Mann–Whitney nonparametric test. Quali-
tative variables are expressed as percentages and were compared with
the Fischer's Exact Test. All P values are two-sided. A P value of .05
was considered signiﬁcant. All analyses were performed using the
MedCalc 14.10 software (MedCalc Software bvba, Ostend, Belgium).
3. Results
3.1. Coronary stents from human explanted hearts
Characteristics of patients and stents are shown in Supplementary
Tables 1 and 2. The mean duration of stent implantation was 34±37
months (the range of stent implant duration was 0.3 to 96 months for
BMSs and 0.3 to 70 months for DESs). BMSs were used only in patients
(11/11) with acute coronary syndromes (ACSs), whereas the 7 DESs
were used in patients with stable angina (4/7) or with ACSs (3/7).
Table 2
Histological characteristics
Human coronary stents All stents (n=20) BMS (n= 13) DES (n=7)
Peristrut foam cells, n (%) 20 (100) 13(100) 7 (100)
Calciﬁcation, n (%)
None 2 (10) 2 (15.5) 0 (0) P=.52
+ 3 (15) 3 (23) 0 (0) P=.52
++ 4 (20) 3 (23) 1 (14.3) P=1.00
+++ 11 (55) 5 (38.5) 6 (85.7) P=.07
Adventitial accumulation of lymphocytes, n (%) 10 (50) 5 (38.5) 5 (71.4) P=.35
Cholesterol crystals, n (%) 7 (35) 3 (23) 4 (57.1) P=.17
Positive Perl's reaction, n (%) 18 (90) 12 (92.3) 6 (85.7) P=1.00
Positive Perl's + DAB reaction, n (%) 20 (100) 13 (100) 7 (100)
Hemoglobin autoﬂuorescence, n (%) 20 (100) 13 (100) 7(100)
Ceroids, n (%) 5 (25) 5 (38) 0 (0) P=.11
Stent thrombosis, n (%) 4 (20) 3 (23) 1 (14.4) P=1.00
Rabbit carotid stents All stents (n= 13) BMS (n=6) DES (n=7)
Peristrut foam cells, n 13 6 7
Positive Perl's reaction, n 4 3 1 P=.26
Positive Perl's + DAB reaction, n 13 6 7
RBC membranes in subintima,an 13 6 7
Presence of phagocytes,bn 13 6 7
Ceroids, n (%) 2 (15.4) 2 (33) 0 (0) P=.19
a Isolectin-B4 staining.
b RAM-11.
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characterized by the presence of foam cells, particularly in peristrut areas,
and the presence of cholesterol crystal clefts, associated with foci of
calciﬁcation, alcianophilic ﬁbrocellular intimal proliferation, medialFig. 1.Histology of neoatherosclerosis in a coronary baremetal stent. The BMSwas implanted 96
a history of ACSs. (A–C) Masson's trichrome. (A and B) The stent strut (black) is surrounded b
crystals of cholesterol accumulation associatedwith free hemoglobin in red. (D)α-actin staining
proteoglycans. (I) Hematoxylin/eosin staining showing RBCs (red arrow) without nuclei and foneoangiogenesis, and adventitial tissue lymphoid clusters (Figs. 1 and 2).
The neoangiogenesis originating from the adventitia was sometimes very
intense, and RBCs were frequently observed in close contact of stent struts
(Fig. 1A and B). As compared to primary coronary atheroma, these lesionsmonths before heart transplantation in the circumﬂex artery of a 58-year-old patientwith
y presence of intact RBCs (B, ×100). (C) Empty clefts corresponding to extracellular solid
in blue. (E and F) Alizarin red staining of hydroxyapatite. (G andH) Alcian blue staining of
am cells (white arrow) in the peristrut area.
Fig. 2. Immune response to in-stent neoatherosclerosis in a paclitaxel-eluting stent. The DES was implanted 285 days before heart transplantation in the proximal section of the left
anterior descending artery in a 52-year-old patient with a history of ACSs. (A) Masson's trichrome: note the leukocytes clusters (red box area) in the adventitial layer surrounded by
adipocytes (E). In the intima, asterisks represent stent struts. (B) Perl's + DAB reaction of the same sample showed iron deposits near the stent strut. (C) Highmagniﬁcation showed, after
Perl's reaction, the presence of iron (blue) in foam cells. (D) CD-3 (green) and CD-20 (red) staining. CD-3 lymphocytes (T cells) are located in the periphery of the cluster, whereas CD-20
lymphocytes (B cells) are in the center. (F) CD68 (red) staining showing the rare presence of phagocytes in the cluster.
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ﬁbrocellular cap, always in relation with peristrut areas at the intima/
media interface.
Peristrut microhemorrhages were found in all cases (Table 2 and
Fig. 3), as detected directly by the presence of intact RBCs (Fig. 1A
and B) or the presence of modiﬁed extracellular hemoglobin associ-
ated with crystal clefts (Fig. 1C), or indirectly by the accumulation of
reactive iron by Perl's reaction and/or Perl's reaction followed by
DAB precipitation (Fig. 3F–I), red autoﬂuorescent ceroids (Fig. 3D),
and glycophorin A immunodetection (Fig. 3E). Due to their different
metabolic pathways and the varied times of sampling with respect to
the evolution of the pathology, these markers were not always
colocalized. Cholesterol crystal clefts were sometimes colocalized
with these markers. Peristrut foam cells were predominantly Perl's
+ DAB positive, providing evidence of iron accumulation within
phagocyte vacuoles. These phagocytes were frequently α-smooth
muscle actin positive.
Calciﬁcations were very frequent (18/20) and mainly developed as
nuclei (Fig. 1F) but were also observed as small focalized deposits, some-
times in a single vSMC (Fig. 1E).
In 50% of the sections (Table 2), lymphocyte clusters, containing B
cells, were detected in the adventitia of the stented coronary artery
(Fig. 2), indicating that an immune response was undergoing matura-
tion within the adventitial layer.
Due to the small number of samples and to the heterogeneity of
stenting duration, it was not possible to establish any histological differ-
ences between DESs and BMSs.3.2. Rabbit samples
Histological characteristics are detailed in Table 2. Atheromatous le-
sions (Fig. 4) in contralateral carotid arteries (controls)were exclusively
composed of focal subendothelial foam cells, protruding into the lumen
(Fig. 4I and L). In contrast, in-stent neoatherosclerosis was associated
with subintimal peristrut foam cell clusters, observed in all samples
(Fig. 4C), and these cells were identiﬁed as vSMCs afterα-smooth mus-
cle actin staining (Fig. 4G andH) and associatedwith Alcian blue (Fig. 4J
and K) staining. RAM 11+ phagocytes were detected in the intima
(Fig. 4F). As in humans, neoangiogenesis was observed, and the pres-
ence of RBCs could be also detected in the peristrut area (Fig. 5E and F).
Control lesionswere negative for iron detection (not shown). In con-
trast, peristrut RBCs were present in stented sections (Fig. 5) and were
characterized by the presence of iron (Perl's and Perl's+DAB reaction),
of isolectin-B4-positive RBCmembranes in the subintima near the stent
struts, and of ceroids. Isolectin-B4 also identiﬁed neovessels and punc-
tual microhemorrhage in close contact of struts (Fig. 5E and F). Con-
trasting with Perl's + DAB positivity, which predominated in peristrut
areas, positive isolectin-B4 staining was not limited to these peristrut
areas but also extended to the intima in close relation to the lumen, in-
dependently of the struts (Fig. 5D). We found that the foam cells were
able to engulf RBCs present in their vicinity (Fig. 5G). Autoﬂuorescent
ceroids were detected in only two BMS samples. In all the samples, a
red autoﬂuorescence was present directly on the metal of the stent
struts, suggesting the presence of hemoglobin not only in the peristrut
area but also at the interface with the metal (Fig. 5I).
Fig. 3. Peristrut hemorrhages after human coronary stenting. (A and B) Paclitaxel-eluting stent implanted 66months before heart transplantation in the right coronary artery of a 52-year-
old patient. (A) Macroscopic view of the stent after longitudinal section. The stent is covered by a neointima, and bleeding in the arterial wall is visible in red. (B) The same stent after
clariﬁcation (whole mount technique) using Perl's staining (green) and Alizarin red (calcium), suggesting iron deposits close to the stent struts. (C and D) BMS implanted in the right
coronary artery 15 days before transplantation in a 64-year-old patient. Autoﬂuorescence at 605-nm wavelength revealing red staining on the stent strut (white asterisk) and the
presence of ceroid rings (D). (E) Immunohistochemistry using anti-glycophorin-A (green) and anti-CD68 (red) antibodies (BMS implanted 10 days before heart transplantation in a
65-year-old patient). The white asterisk localizes the stent strut. (F) Perl's + DAB reaction (paclitaxel-eluting stent implanted 70 months before transplantation in the circumﬂex
artery of a 56-year-old patient). (G–I) Perl's (G) and Perl's + DAB reaction (H and I) of a BMS implanted 96 months before heart transplantation in the circumﬂex artery of a 58-year-
old patient. Red asterisks correspond to stent struts location.
34 Z. Terzian et al. / Cardiovascular Pathology 26 (2016) 30–383.3. Biomechanical stress induced by solid strut/soft arterial wall interac-
tions (Fig. 6)
The von Mises stress plot from our FE analysis is shown in Fig. 6b.
This plot nicely illustrates that stenting approximately doubles the
local von Mises stress in the intimal layer, i.e., from about 70 kPa that
is seen in the intimal sections away from the stent strut to peaks of
150 kPa directly underneath the stent strut. Naturally, the normal stress
in the radial vessel direction (radial normal stress), i.e., along which the
strut pushes, is massively inﬂuenced. Speciﬁcally, in our simulation,
stenting elevated the magnitude of the local radial stress from
13.3 kPa (100mmHg) to about 200 kPa (Fig. 6c). Finally, the inhomoge-
neous loading by stent struts causes local shear stress in the radial–
longitudinal plane and close to the strut (Fig. 6d). The magnitude of
this shear stress increases from zero kPa (solution of the inﬂated axi-
symmetric vessel) to peaks at 55 kPa.
4. Discussion
In our studies of stent pathology, we consistently found in-stent
neoatherosclerosis, both in a series of human coronary stents obtained
from explanted hearts before heart transplantation and in an experimental
model of carotid stenting in the hypercholesterolemic rabbit. Severalmech-
anisms have been suggested [16] like foreign body chronic inﬂammation as
a response to the stent, aberrant endothelial cell function, and incomplete
cell coverage. Neoatherosclerotic lesions are located predominantly in thedeeper layers of the subintima, around the stent struts, rebutting an endo-
thelial dysfunction ore a defect in cell coverage. This observation, together
with the results of our ﬁnite element study, strongly suggests that the bio-
mechanical interaction between the rigid stent struts and the surrounding
soft tissue may play a causal role in neoatherosclerosis formation. In addi-
tion, both in humans and in the rabbitmodel, we found RBCs and oxidative
iron in the vicinity of the stent struts, which may be a consequence of the
frictionat the stent strut/vesselwall interfaceduring thecardiac cycle. Final-
ly, neoatherosclerosis was often associated with an immune adaptative re-
sponse in the adventitia. Our results are in line with the ﬁndings of
Nakazawa et al. [7], who studied a large autopsy cohort of stents; described
lesion morphologies, including plaque rupture, ﬁbroatheroma, calciﬁca-
tions, and pathological intimal thickening; and ﬁnally compared BMSs
and DESs. However, our observations signiﬁcantly extend the latter study,
providing additional information on peristrut microhemorrhages.
4.1. Peristrut hemorrhages
Because of their rigidity, stents cannot fully accompany the pulsatility
(extension and retraction) of epicardial coronary vessels during the cyclic
stretches imposed by systolodiastolic motion. The interface between the
solid metallic material of the stent and the soft viscoelastic arterial wall is
therefore subjected to very speciﬁc stresses. Such biomechanical mismatch
has been studied in the context of arterialwall calciﬁcations associatedwith
atherosclerosis [17,18] but not in relation to the arterial wall reaction to
stent implantation. In this context, rigid inclusions (calciﬁcations or struts)
Fig. 4.Histology of in-stent neoatheroma in rabbit carotid arteries after implantation of a BMS. (A–C)Masson's trichrome. Themedia is represented by the yellow arrow; the neointima, by
the red arrow. The asterisk denotes the stent strut location. At high magniﬁcation of the boxed area in B, foam cells are visible in the subintima (red asterisks), corresponding to
neoatherosclerotic lesions, close to the stent strut. (D–F) RAM 11 staining. RAM 11 appears brown in the subintima (red arrow) between two stent struts (asterisks). There is no RAM
11 staining in the media (yellow arrow). The high magniﬁcation of the boxed area shows RAM 11 staining of the foam cells (phagocytes) located close to the stent strut (asterisk). (G
and H) α-actin staining appearing in brown in the neointima and in the media. (I and L) Controls (nonstented left carotid artery). Foam cell (black arrow) accumulation is present in
the subendothelial layer; budding (boxed area), in the arterial lumen). (J and K) Alcian blue. Blue staining appears in the media and subintima. Background of foam cells is positive for
glycosaminoglycan staining.
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with tears at the interface between compliant (soft tissue) and noncompli-
ant (struts) components. We found that calciﬁcations, which are also hard
tissues, cause “pericalciﬁcation hemorrhages” in the surrounding tissue
with iron deposits detected by Perl's and Perl's + DAB reaction (Fig. 3).
This observation conﬁrms the presence of a physical frontier between
hard and soft tissues, which has consequences for the biology of the tissue
in the vicinity of this interface. Similarly to pericalciﬁcation hemorrhages
[19], stenting not only severely elevates local stress levels but also intro-
duces a completely nonphysiological stress pattern. Due to the pulsatile
loading of the vasculature, such stress may lead to fatigue-like
microdamage, i.e., microscopic tears of the soft tissue surrounding the
stent as observed in the present study.Most importantly, the layered struc-
ture of the vessel wall may be vulnerable either to the nonphysiological
shear stress in the radial longitudinal plane (Fig. 6d) or to the high von
Mises stress induced by stenting, which in turn may trigger microscopic
tears. This compliant mismatch leading to intratissular microhemorrhages
could explain the accelerated nature of in-stent neoatherosclerosis as com-
pared to atherosclerosis arising in native arteries.
4.2. From peristrut microhemorrhages to in-stent neoatherosclerosis
Whereas intraplaque hemorrhages are involved in the progression
of atherosclerotic lesions [20], leading to their vulnerability and rupture
[2], peristrut microhemorrhages with accumulation of RBCs appear to
be at the origin of in-stent neoatherosclerotic lesions. RBCs lose their
cellular structure and release membranous lipids and hemoglobin.RBCmembranes are particularly rich in free and unesteriﬁed cholesterol
[21] and are hence a source of cholesterol crystal formation in
intraplaque hemorrhage [10,22].
Hemoglobin, composed of globin and iron-rich heme, is phagocy-
tosed, forming foam cells [23], and undergoes proteolysis, producing
globin degradation products and free heme. In physiologic conditions,
heminic iron is in the ionized ferrous form (Fe2+, oxyhemoglobin)
[24]. Fe3+ heme (ferric methemoglobin) dissociates more easily from
globin than Fe2+, releasing deleterious hydrophobic free heme/iron
[25]. Heme ismetabolized by HO-1 to produce free iron, CO, and biliver-
din [2]. Ionized iron can mediate oxidative modiﬁcations of lipids, pro-
teins, and DNA and cause cytotoxicity [26,27], and therefore ampliﬁes
the oxidation capacity (Fenton andHaber–Weiss reactions) of biological
systems [28]. Iron retention can be visualized by Prussian blue (Perl's)
reaction. The use of Perl's + DAB reaction was required to increase sen-
sitivity [12]. It is now well established that the presence of RBCs within
the arterial wall in humans [10] as well as in rabbits [29] enhances the
development of atherosclerosis. Our histologic results are also in line
with previous OCT ﬁndings [30].
4.3. Adventitial adaptive immune response to in-stent neoatherosclerosis
After arterial injury, remodeling involves the entire wall. The adven-
titia is the outermost layer of the arterialwall, in which the adaptive im-
mune response takes place [31]. In our study, we noted an adaptive
immune reaction resulting in tertiary lymphoid organs (tissue lym-
phoid clusters) formation not only with T cells but also with the
Fig. 5. Histology of peristrut hemorrhages in rabbit stenting. (A–C) Iron presence. (A) General view of Perl's + DAB reaction showing a large quantity of iron (brown staining) in the
peristrut (asterisks) areas. (B)– High magniﬁcation of the black boxed area in A suggesting that iron is preferentially located in peristrut areas. (C) Iron is visualized by Perl's staining
(blue asterisks) in the same areas as in B. (D–G) Isolectin B4 staining (IB4). (D) Intact RBCs are located in the lumen (red arrow), and IB4 staining is positive in the intima (brown). (E
and F) A vascular structure is located close to the stent strut location (white), with intact RBCs (F). (G) IB4 staining is positive in peristrut areas (yellow arrow) and in foam cells (red
arrows), suggesting that RBCs have been phagocytosed by foam cells. (H and I) Ceroids are visible at a wavelength of 605 nm and show a red autoﬂuorescence (H, white arrow). Note
the red autoﬂuorescence of the stent strut (white asterisk), also at 605-nm wavelength (I).
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to in-stent RBCs and oxidation-rich neoatherosclerosis. These lympho-
cyte tissue clusters are reminiscent of tertiary lymphoid organs de-
scribed in chronic rejection [32], atherosclerosis [33], and aortic
aneurysms [34]. These results suggest a relationship between intramu-
ral RBC release, tissue oxidation, and the development of an adaptive
immune response within the adventitia.
4.4. Clinical relevance
Peristrut RBC release, the adventitial immune response, and in-stent
neoatherosclerosis may all participate in the formation of an “in-stent
vulnerable plaque” phenotype which has been described in postmor-
tem studies of late and very late stent thrombosis [35,36].
4.5. Limits
First, neither our human nor our experimental studies were sufﬁ-
ciently powered to detect a qualitative or quantitative difference be-
tween the neoatherosclerotic lesions of BMSs versus DESs. The proﬁle
of patients in our study (severe ischemic cardiomyopathy treated by
heart transplantation) and the limited number of cases could explain
the high frequency of in-stent neoatherosclerosis and the absence of dif-
ference between DESs and BMSs. Second, in the experimental rabbit
model, the delay between stent implantation and sampling was rela-
tively short (4 weeks), probably explaining why cholesterol crystals,
calciﬁcations, or tissue lymphoid clusters were not observed. But it
allowed us to conﬁrm the presence and putative role of peristrut RBCrelease in the formation of iron-rich foam cells. Third, methacrylate em-
bedding limits the use of immunohistochemistry. This point probably
explains why we did not succeed in immunostaining microvessels by
CD31 antibodies even in the adventitia.
5. Conclusion
This observational and experimental study, despite the relatively
limited number of samples analyzed, highlights peristrut
microhemorrhages and RBC accumulation andmetabolism as a possible
cause of the formation of in-stent neoatherosclerotic lesions. Our data
strongly suggest that these lesions are induced by the physical shear be-
tween themetallic strut and the soft arterial wall, which display speciﬁc
stress features during systole/diastolic motion.
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Fig. 6. Stress analysis of a stented coronary artery: (A) idealizedmodelwith dimensions. The vessel segment denoted by “Simulation domain”wasmodeledwith the FEmethod in order to
investigate wall stress underneath the stent strut. (B) von Mises stress distribution in the coronary vessel wall illustrating that stenting doubles the local stress level in the intimal layer.
(C) Normal stress in the radial vessel direction reaches a compression of 200 kPa underneath the stent strut. (D) Inhomogeneous loading by the stent struts causes local shear stress
magnitudes of 55 kPa in the longitudinal–radial plane of the vessel wall.
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